Nucleotide excision repair is a predictor of early relapse in pediatric acute lymphoblastic leukemia
Abstract Background Nucleotide Excision Repair (NER) is a major pathway of mammalian DNA repair that is associated with drug resistance and has not been well characterized in acute lymphoblastic leukemia (ALL). The objective of this study was to explore the role of NER in relapsed ALL patients. We h...
Main Authors: | Omar M. Ibrahim, Homood M. As Sobeai, Stephen G. Grant, Jean J. Latimer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12920-018-0422-2 |
Similar Items
-
Mutational profiling of acute lymphoblastic leukemia with testicular relapse
by: Ling-Wen Ding, et al.
Published: (2017-03-01) -
Patient with Down syndrome and relapsed acute lymphoblastic leukemia with sustained remission despite only partial R3 chemotherapy
by: Zhongbo Hu, et al.
Published: (2021-03-01) -
DNA methylation as a prognostic marker i acute lymphoblastic leukemia
by: Borssén, Magnus
Published: (2016) -
Unilateral leukemic infiltration and acute angle closure as the first sign of B-cell acute lymphoblastic leukemia relapse
by: Silva, Diana, et al.
Published: (2019-04-01) -
Unilateral hypopyon in a child as a first and sole presentation in relapsing acute lymphoblastic leukemia
by: Wadhwa Neeraj, et al.
Published: (2007-01-01)